Coherus Oncology
CHRS
CHRS
137 hedge funds and large institutions have $198M invested in Coherus Oncology in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 38 increasing their positions, 56 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
32% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 56
45% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 42
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
137
Holding in Top 10
–
Calls
$666K
Puts
$684K
Top Buyers
| 1 | +$23.9M | |
| 2 | +$2.52M | |
| 3 | +$2.1M | |
| 4 |
CC
Clearline Capital
New York
|
+$1.87M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.8M |
Top Sellers
| 1 | -$8.26M | |
| 2 | -$5.38M | |
| 3 | -$3.79M | |
| 4 |
Morgan Stanley
New York
|
-$3.53M |
| 5 |
Barclays
London,
United Kingdom
|
-$3.39M |